HEPION PHARM INC PFD closed fiscal year 2025 with $3.1M in total assets, $402K in total liabilities and $2.7M in shareholder equity. This represents an increase of 90.2% from the prior fiscal year. The table below carries 13 fiscal years, from 2014 to 2025, and the quarters HEPION PHARM INC PFD has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CTRVP Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1410-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.1M+90.2% | $1.6M-91.1% | $18.1M-70.0% | $60.2M-41.8% | $103.6M+112.9% | $48.6M+136.0% | $20.6M+151.7% | $8.2M-55.5% | $18.4M+40.3% | $13.1M+143.7% | $5.4M+168.7% | $2.0M | $2.6M |
| Total Liabilities | $402K-88.4% | $3.5M-67.8% | $10.8M+4.1% | $10.4M-1.6% | $10.6M+29.9% | $8.1M+62.7% | $5.0M-19.6% | $6.2M-33.4% | $9.3M-20.9% | $11.8M+508.3% | $1.9M-60.7% | $4.9M | $10.0M |
| Total Equity | $2.7M+243.2% | -$1.9M-125.6% | $7.3M-85.4% | $49.9M-46.4% | $93.0M+129.5% | $40.5M+159.5% | $15.6M+805.4% | $1.7M-81.0% | $9.1M+587.5% | $1.3M-61.7% | $3.4M+217.2% | -$2.9M | -$7.3M |
CTRVP Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.9M-57.2% | $2.7M-57.2% | $3.1M+90.2% | $3.7M+0.7% | $4.5M-25.0% | $6.3M-60.5% | $1.6M-91.1% | $3.7M-85.1% | $6.0M-83.5% | $16.0M-67.7% | $18.1M-70.0% | $25.0M-64.1% |
| Total Liabilities | $649K-8.4% | $849K-65.0% | $402K-88.4% | $416K-89.9% | $709K-71.1% | $2.4M-71.4% | $3.5M-67.8% | $4.1M-53.4% | $2.4M-75.8% | $8.5M-31.4% | $10.8M+4.1% | $8.8M-15.3% |
| Total Equity | $1.3M-66.3% | $1.9M-52.3% | $2.7M+243.2% | $3.3M+717.4% | $3.8M+6.6% | $3.9M-48.2% | -$1.9M-125.6% | $407K-97.5% | $3.6M-86.5% | $7.5M-79.8% | $7.3M-85.4% | $16.2M-72.7% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More HEPION PHARM INC PFD financials
Frequently Asked Questions
What was HEPION PHARM INC PFD's total assets in fiscal year 2025?
HEPION PHARM INC PFD closed fiscal year 2025 with $3.1M in total assets, $402K in total liabilities and $2.7M in shareholder equity.
How fast is HEPION PHARM INC PFD's total assets growing?
HEPION PHARM INC PFD (CTRVP) total assets rose by 90.2% year over year, from $1.6M to $3.1M in fiscal year 2025.
How has HEPION PHARM INC PFD's total assets changed over the years?
Across the 13 fiscal years this page covers, HEPION PHARM INC PFD (CTRVP) total assets went from $2.6M in fiscal year 2014 to $3.1M in fiscal year 2025.
What was HEPION PHARM INC PFD's total assets in the most recent quarter?
HEPION PHARM INC PFD (CTRVP) reported $1.9M in total assets in Q2 2026. This represents a decrease of 57.2% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what HEPION PHARM INC PFD (CTRVP) reported on that line in every period on record.